Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INMD InMode	$14.94 +0.1%	$14.41	$13.14 ▼ $19.85	$944.36M	1.93	1.27 million shs	1.58 million shs
MDXG MiMedx Group	$7.10 -1.1%	$6.75	$5.47 ▼ $10.14	$1.05B	1.79	680,059 shs	347,633 shs
PLSE Pulse Biosciences	$15.54 -0.1%	$15.50	$13.77 ▼ $25.00	$1.05B	1.6	172,087 shs	91,586 shs
SMTI Sanara MedTech	$33.66 -0.2%	$28.37	$23.53 ▼ $39.08	$299.64M	1.26	33,984 shs	17,160 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INMD InMode	-1.78%	+5.00%	+4.26%	+1.57%	-4.73%
MDXG MiMedx Group	+0.14%	+2.13%	+7.65%	+10.97%	+8.62%
PLSE Pulse Biosciences	-1.83%	-2.75%	+5.78%	-10.88%	-14.93%
SMTI Sanara MedTech	-0.62%	+10.52%	+34.81%	+18.73%	-1.23%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INMD InMode	2.2573 of 5 stars	2.1	2.0	0.0	3.8	1.7	1.9
MDXG MiMedx Group	3.4117 of 5 stars	3.5	4.0	0.0	4.2	1.7	0.6
PLSE Pulse Biosciences	4.0082 of 5 stars	3.5	0.0	4.2	3.0	4.2	0.0
SMTI Sanara MedTech	2.0052 of 5 stars	3.5	1.0	0.0	2.1	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INMD InMode	2.13	Hold	$18.04	20.76% Upside
MDXG MiMedx Group	3.00	Buy	$12.00	69.01% Upside
PLSE Pulse Biosciences	3.00	Buy	$22.00	41.57% Upside
SMTI Sanara MedTech	3.00	Buy	$50.00	48.54% Upside

Current Analyst Ratings Breakdown

Latest SMTI, PLSE, MDXG, and INMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2025	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$53.00 ➝ $54.00
8/18/2025	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$53.00 ➝ $54.00
7/31/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$11.00 ➝ $12.00
7/30/2025	INMD InMode	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/30/2025	INMD InMode	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$24.00 ➝ $21.00
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/11/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$15.00
7/7/2025	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00

(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INMD InMode	$394.82M	2.39	$1.79 per share	8.33	$9.94 per share	1.50
MDXG MiMedx Group	$363.77M	2.89	$0.33 per share	21.64	$1.46 per share	4.86
PLSE Pulse Biosciences	$700K	1,493.62	N/A	N/A	$1.55 per share	10.03
SMTI Sanara MedTech	$97.24M	3.08	N/A	N/A	$3.98 per share	8.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INMD InMode	$181.27M	$2.47	6.05	8.21	N/A	44.50%	18.38%	16.35%	10/29/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.21	33.81	22.19	N/A	8.84%	23.03%	17.09%	10/29/2025 (Estimated)
PLSE Pulse Biosciences	-$53.58M	-$1.05	N/A	∞	N/A	N/A	-63.19%	-54.98%	10/29/2025 (Estimated)
SMTI Sanara MedTech	-$9.66M	-$1.16	N/A	N/A	N/A	-10.22%	-26.43%	-10.69%	11/11/2025 (Estimated)

Latest SMTI, PLSE, MDXG, and INMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	SMTI Sanara MedTech	-$0.33	-$0.23	+$0.10	-$0.23	$25.15 million	$25.83 million
8/12/2025	Q2 2025	PLSE Pulse Biosciences	-$0.26	-$0.28	-$0.02	-$0.28	$0.50 million	N/A
7/30/2025	Q2 2025	INMD InMode	$0.50	$0.47	-$0.03	$0.42	$98.45 million	$95.60 million
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	$0.10	+$0.04	$0.06	$90.79 million	$98.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INMD InMode	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INMD InMode	N/A	9.60	8.58
MDXG MiMedx Group	0.08	4.39	3.90
PLSE Pulse Biosciences	N/A	12.05	12.04
SMTI Sanara MedTech	1.25	2.26	2.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INMD InMode	68.04%
MDXG MiMedx Group	79.15%
PLSE Pulse Biosciences	76.95%
SMTI Sanara MedTech	8.10%

Insider Ownership

Company	Insider Ownership
INMD InMode	6.92%
MDXG MiMedx Group	1.70%
PLSE Pulse Biosciences	71.50%
SMTI Sanara MedTech	42.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
MDXG MiMedx Group	870	147.96 million	145.44 million	Optionable
PLSE Pulse Biosciences	140	67.28 million	19.17 million	Optionable
SMTI Sanara MedTech	60	8.90 million	5.11 million	Not Optionable

SMTI, PLSE, MDXG, and INMD Headlines

Recent News About These Companies

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

August 27 at 4:05 PM | globenewswire.com

Sanara Medtech Inc News (SMTI) - Investing.com

August 23, 2025 | investing.com

Q3 EPS Estimates for Sanara MedTech Boosted by HC Wainwright

August 22, 2025 | marketbeat.com

Q3 EPS Estimates for Sanara MedTech Lifted by HC Wainwright

August 22, 2025 | americanbankingnews.com

HC Wainwright Forecasts Sanara MedTech Q1 Earnings

August 21, 2025 | marketbeat.com

HC Wainwright Comments on Sanara MedTech Q1 Earnings

August 21, 2025 | americanbankingnews.com

FY2025 EPS Estimate for Sanara MedTech Raised by Analyst

August 19, 2025 | marketbeat.com

FY2025 EPS Estimates for Sanara MedTech Raised by Analyst

August 19, 2025 | americanbankingnews.com

Sanara MedTech price target raised to $54 from $53 at H.C. Wainwright

August 18, 2025 | msn.com

Sanara MedTech (NASDAQ:SMTI) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS

August 16, 2025 | marketbeat.com

Sanara MedTech Reports Strong Revenue Growth in Q2 2025

August 14, 2025 | msn.com

Sanara MedTech Inc. (NASDAQ:SMTI) Q2 2025 Earnings Call Transcript

August 14, 2025 | msn.com

Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript

August 13, 2025 | seekingalpha.com

Sanara MedTech Sales Jump 28 Percent

August 13, 2025 | theglobeandmail.com

Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates

August 13, 2025 | zacks.com

Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)

August 13, 2025 | globenewswire.com

Sanara MedTech Inc (SMTI) Q2 2025: Everything You Need To Know Ahead Of Earnings

August 12, 2025 | finance.yahoo.com

Sanara MedTech (NASDAQ:SMTI) investors are sitting on a loss of 12% if they invested three years ago

August 10, 2025 | finance.yahoo.com

Sanara MedTech (SMTI) to Release Earnings on Wednesday

August 6, 2025 | marketbeat.com

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

July 15, 2025 | globenewswire.com

Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program

July 14, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMTI, PLSE, MDXG, and INMD Company Descriptions

InMode NASDAQ:INMD

$14.94 +0.02 (+0.13%)

Closing price 04:00 PM Eastern

Extended Trading

$14.92 -0.03 (-0.17%)

As of 05:38 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

MiMedx Group NASDAQ:MDXG

$7.10 -0.08 (-1.11%)

Closing price 04:00 PM Eastern

Extended Trading

$7.09 -0.01 (-0.14%)

As of 04:53 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Pulse Biosciences NASDAQ:PLSE

$15.54 -0.02 (-0.13%)

Closing price 04:00 PM Eastern

Extended Trading

$16.02 +0.48 (+3.12%)

As of 04:20 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Sanara MedTech NASDAQ:SMTI

$33.66 -0.07 (-0.21%)

Closing price 04:00 PM Eastern

Extended Trading

$33.64 -0.02 (-0.07%)

As of 04:10 PM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time